OMIC Singular Genomics Corp: Year-over-year earnings per share growth for the last twelve months
Singular Genomics Systems (OMIC) develops DNA analysis equipment, overcoming high R&D costs and pressure from industry leaders. Success is based on the funding of scientific centers and the precision of biomolecular tests. The geopolitical backdrop remains neutral due to the medical status of the products. The quarterly EPS growth rate reflects the market consensus, with the value stabilizing at 26.80.
Analytical breakdowns for Singular Genomics Systems
- share price and expert price forecast:
- company stock capitalization data:
- book capitalization data:
- business debt structure and liquidity details:
Total Debt to Capital Singular Genomics Systems|OMIC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Singular Genomics Systems|OMIC - Company Aggregate Debt|Debt to Book Capitalization Ratio Singular Genomics Systems Inc|OMIC - Long-Term Debt|Company Short-Term Debt Singular Genomics|Quick Ratio singulargenomics.com
- earnings and valuation multiples information:
OMIC - Net Financial Result|Projected Future Earnings Singular Genomics Systems|OMIC - Price to Earnings Ratio|Future Price to Earnings Singular Genomics Systems Inc|OMIC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Singular Genomics Systems Inc|OMIC - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Singular Genomics|OMIC - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months singulargenomics.com|OMIC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Singular Genomics Systems
Summary company analysis:Singular Genomics Systems
The quarterly earnings per share growth rate measures the dynamics of net operating efficiency, reflecting the business's ability to scale revenue relative to the volume of shares outstanding. By analyzing the relative quarterly change in EPS at 26.80, an investor assesses the extent to which investments in the leading bioengineering staff at Singular Genomics (OMIC) translate into real financial results and growth in shareholder value.
Analysis of competing companies
TEM: Quarterly EPS earnings growth|Qiagen NV (QGEN) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Ionis Pharma|RGEN: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months RNA (Avidity Biosciences)|CRSP (crisprtx.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx)|Net earnings per share growth for the trailing year Ultragenyx Pharmaceutical Inc.|Beam Therapeutics Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Sarepta Corp|Twist Bioscience (TWST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months TXG|Year-over-year earnings per share growth for the last twelve months Intellia Therapeutics, Inc.|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics Inc STOK|Year-over-year earnings per share growth for the last twelve months BioLife Corp (BLFS)|Year-over-year net earnings per share growth for the last 12 months Wave Pharma WVE|Quarterly EPS earnings growth MAZE (Maze Therapeutics Inc)|Year-over-year net earnings per share change for the last twelve months sionnatx.com (SION)|Prime Medicine - Quarterly EPS earnings growth|Taysha Gene Therapies Inc (TSHA) - Year-over-year net earnings per share growth for the last 12 months|uniQure Corp (QURE) - Year-over-year earnings per share growth for the last twelve months|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Ocugen (OCGN)|Year-over-year net earnings per share change for the last twelve months Pacific Biosciences of California, Inc.|Benitec - Year-over-year net earnings per share growth for the last 12 months|Design Corp (DSGN) - Earnings per share growth in annualized terms for the last twelve months|RCKT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months 4dmoleculartherapeutics.com FDMT|LXEO (lexeotx.com) - Year-over-year net earnings per share growth for the last 12 months|KRRO: Year-over-year earnings per share growth rate for the last twelve months|EDIT (Editas) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Silence Therapeutics Corp SLN|Year-over-year earnings per share growth for the last twelve months ProQR Therapeutics N.V. (PRQR)|Year-over-year net earnings per share growth for the last 12 months codexis.com CDXS|Year-over-year earnings per share growth for the last twelve months Sangamo Therapeutics, Inc. SGMO|Year-over-year net earnings per share change for the last twelve months Nautilus Biotechnology, Inc. (NAUT)|MGX - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months precisionbiosciences.com|generationbio.com (GBIO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months boundlessbio.com|XCUR (Exicure Inc.) - Quarterly EPS earnings growth|Celsion Corporation (IMNN) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth PHIO|Year-over-year net earnings per share growth for the last 12 months mustangbio.com MBIO|Quarterly EPS earnings growth RNAZ (TransCode Therapeutics, Inc.)|BNGO: Year-over-year earnings per share growth for the last 12 months|APDN - Year-over-year earnings per share growth for the last twelve months|BLUE (bluebird bio Inc.) - Year-over-year earnings per share growth for the last 12 months|IPA: Quarterly EPS earnings growth|Omega Therapeutics Corp (OMGA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Regulus Therapeutics|syros.com (SYRS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth TBIO|Year-over-year net earnings per share change for the last twelve months TRACON Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX
